Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

Archive ouverte

Routy, Bertrand | Le Chatelier, Emmanuelle | Derosa, Lisa | Duong, Connie | Alou, Maryam Tidjani | Daillère, Romain | Fluckiger, Aurélie | Messaoudene, Meriem | Rauber, Conrad | Roberti, Maria | Fidelle, Marine | Flament, Caroline | Poirier-Colame, Vichnou | Opolon, Paule | Klein, Christophe | Iribarren, Kristina | Mondragón, Laura | Jacquelot, Nicolas | Qu, Bo | Ferrere, Gladys | Clemenson, Céline | Mezquita, Laura | Masip, Jordi Remon | Naltet, Charles | Brosseau, Solenn | Kaderbhai, Coureche | Richard, Corentin | Rizvi, Hira | Levenez, Florence, F. | Galleron, Nathalie | Qu, Benoit | Pons, Nicolas | Ryffel, Bernhard | Minard-Colin, Véronique | Gonin, Patrick | Soria, Charles | Deutsch, Eric | Loriot, Yohann | Ghiringhelli, François | Zalcman, Gérard | Goldwasser, François | Escudier, Bernard | Hellmann, Matthew | Eggermont, Alexander, M | Raoult, Didier | Albiges, Laurence | Kroemer, Guido | Zitvogel, Laurence

Edité par CCSD ; American Association for the Advancement of Science (AAAS) -

International audience. Immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis induce sustained clinical responses in a sizable minority of cancer patients. We found that primary resistance to ICIs can be attributed to abnormal gut microbiome composition. Antibiotics inhibited the clinical benefit of ICIs in patients with advanced cancer. Fecal microbiota transplantation (FMT) from cancer patients who responded to ICIs into germ-free or antibiotic-treated mice ameliorated the antitumor effects of PD-1 blockade, whereas FMT from nonresponding patients failed to do so. Metagenomics of patient stool samples at diagnosis revealed correlations between clinical responses to ICIs and the relative abundance of Akkermansia muciniphila Oral supplementation with A. muciniphila after FMT with nonresponder feces restored the efficacy of PD-1 blockade in an interleukin-12-dependent manner by increasing the recruitment of CCR9+CXCR3+CD4+ T lymphocytes into mouse tumor beds.

Consulter en ligne

Suggestions

Du même auteur

Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer

Archive ouverte | Roberti, Maria Paula | CCSD

International audience. The prognosis of colon cancer (CC) is dictated by tumor-infiltrating lymphocytes, including follicular helper T (TFH) cells and the efficacy of chemotherapy-induced immune responses. It remai...

A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers

Archive ouverte | Fidelle, Marine | CCSD

International audience. Antibiotics (ABX) compromise the efficacy of programmed cell death protein 1 (PD-1) blockade in cancer patients, but the mechanisms underlying their immunosuppressive effects remain unknown. ...

A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers

Archive ouverte | Fidelle, Marine | CCSD

International audience. Antibiotics (ABX) compromise the efficacy of programmed cell death protein 1 (PD-1) blockade in cancer patients, but the mechanisms underlying their immunosuppressive effects remain unknown. ...

Chargement des enrichissements...